PIM1 and glioblastoma: Notably, the dimeric flavonoids exhibited a stronger binding affinity to PIM1 compared to apigenin itself, suggesting that the dimeric forms may be more effective in inhibiting PIM1 activity, which could enhance their therapeutic potential against GBM [214].